These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 32101780)

  • 1. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
    Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
    Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease.
    Rosales Hernández MC; Olvera-Valdez M; Velazquez Toledano J; Mendieta Wejebe JE; Fragoso Morales LG; Cruz A
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemicals-based β-amyloid cleaving enzyme-1 and MAO-B inhibitors for the treatment of Alzheimer's disease: molecular simulations-based predictions.
    Mahnashi MH; Ayaz M; Ghufran M; Almazni IA; Alqahtani O; Alyami BA; Alqahtani YS; Khan HA; Sadiq A; Waqas M
    J Biomol Struct Dyn; 2024 Oct; 42(16):8359-8371. PubMed ID: 37815007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis.
    Nozal V; García-Rubia A; Cuevas EP; Pérez C; Tosat-Bitrián C; Bartolomé F; Carro E; Ramírez D; Palomo V; Martínez A
    Angew Chem Int Ed Engl; 2021 Aug; 60(35):19344-19354. PubMed ID: 34169618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
    Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
    Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
    Iraji A; Firuzi O; Khoshneviszadeh M; Tavakkoli M; Mahdavi M; Nadri H; Edraki N; Miri R
    Eur J Med Chem; 2017 Dec; 141():690-702. PubMed ID: 29107423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents.
    Gupta SP; Patil VM
    Curr Top Med Chem; 2020; 20(13):1195-1213. PubMed ID: 32297584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 in Alzheimer's disease.
    Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
    Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
    Khalid S; Zahid MA; Ali H; Kim YS; Khan S
    BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-target-directed ligands in Alzheimer's disease treatment.
    Bajda M; Guzior N; Ignasik M; Malawska B
    Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACE1 as a therapeutic target in Alzheimer's disease: rationale and current status.
    Evin G; Hince C
    Drugs Aging; 2013 Oct; 30(10):755-64. PubMed ID: 23842796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.
    Estrada M; Pérez C; Soriano E; Laurini E; Romano M; Pricl S; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
    Future Med Chem; 2016 Jul; 8(11):1191-207. PubMed ID: 27402296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of BACE1, MAO-B, cholinesterase enzymes, and anti-amyloidogenic potential of selected natural phytoconstituents: Multi-target-directed ligand approach.
    Chowdhury S; Kumar S
    J Food Biochem; 2021 Jan; 45(1):e13571. PubMed ID: 33249607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Structural Modification of BACE1 Inhibitors.
    Gu T; Wu WY; Dong ZX; Yu SP; Sun Y; Zhong Y; Lu YT; Li NG
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28025519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.